A killer choice for cancer immunotherapy.

  title={A killer choice for cancer immunotherapy.},
  author={Tobi L Schmidt and Robert S. Negrin and Christopher H. Contag},
  journal={Immunologic research},
  volume={58 2-3},
The promise of cell-based immunotherapies for the treatment of cancer offers the potential of therapeutic synergy with chemo- and radiotherapies that may overcome current limitations leading to durable responses and prevention of recurrence. There is a wide array of cell-based immunotherapies that are either poised to enter cancer clinical trials or are in clinical trials, and many are showing some success. Yet within this field, there are clear obstacles that need to be overcome, including… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
8 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…